Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 31.37

-0.6%

12:42 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Doug who wrote (242)	8/13/1998 4:33:00 PM
From: Harold Engstrom	Read Replies (2) of 340

Teva came to my attention because of my investment in another company. It makes COP-1, an inferior product for many reasons to Avonex. So, lo and behold, when at the annual meeting of the company that makes Avonex, it is shown that Copaxone has 18% of US market share despite having to take it more often that interferon and despite its not been show to slow the progression of MS. I thought, "Wow, these guys have 18% with a relatively poor product: they must be great marketers." So, I started looking into the company. well, they are good marketers. And they have tons of new products coming down the pipeline. And they make money right now. And they can compete on price - they are primarily a generics manufacturer. So, I bought some stock. I think they are a good holding for a shaky market. If estimates for the next year are accurate, the share price should appreciate even in the face of a flat or slightly declining market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next